These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17206750)

  • 21. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Xie Y
    Adv Exp Med Biol; 2017; 1018():11-21. PubMed ID: 29052129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B Virus Infection: Overview.
    Li H; Yan L; Shi Y; Lv D; Shang J; Bai L; Tang H
    Adv Exp Med Biol; 2020; 1179():1-16. PubMed ID: 31741331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative Abundance of Integrant-Derived Viral RNAs in Infected Tissues Harvested from Chronic Hepatitis B Virus Carriers.
    Freitas N; Lukash T; Gunewardena S; Chappell B; Slagle BL; Gudima SO
    J Virol; 2018 May; 92(10):. PubMed ID: 29491161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review.
    Baugh SDP
    Infect Disord Drug Targets; 2017; 17(1):24-35. PubMed ID: 28056752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
    Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
    Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus-induced hepatocellular carcinoma with special emphasis on HBV.
    Wang M; Xi D; Ning Q
    Hepatol Int; 2017 Mar; 11(2):171-180. PubMed ID: 28097530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B virus pre-S/S variants in liver diseases.
    Chen BF
    World J Gastroenterol; 2018 Apr; 24(14):1507-1520. PubMed ID: 29662289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards the elimination of hepatitis B and hepatocellular carcinoma.
    Spearman CW
    S Afr Med J; 2018 Aug; 108(8b):13-16. PubMed ID: 30182907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives and control of hepatitis B virus infection in Taiwan.
    Lin CL; Kao JH
    J Formos Med Assoc; 2015 Oct; 114(10):901-9. PubMed ID: 26184565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward elimination and eradication of hepatitis B.
    Chen DS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):19-25. PubMed ID: 20136972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiviral therapy and resistance with hepatitis B virus infection.
    Tillmann HL
    World J Gastroenterol; 2007 Jan; 13(1):125-40. PubMed ID: 17206760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
    Koike K
    Nihon Rinsho; 1999 Jan; 57(1):213-9. PubMed ID: 10036965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiviral treatment for hepatitis B virus recurrence following liver transplantation.
    Lee S; Kwon CH; Moon HH; Kim TS; Roh Y; Song S; Shin M; Kim JM; Park JB; Kim SJ; Joh JW; Lee SK
    Clin Transplant; 2013; 27(5):E597-604. PubMed ID: 24093615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A; Nishiguchi S; Kubo S; Narimatsu T; Habu D; Takeda T; Hirohashi K; Shiomi S
    J Med Virol; 2003 Dec; 71(4):492-8. PubMed ID: 14556260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.